Literature DB >> 31857941

FRONTAL ALPHA ASYMMETRY IN YOUTH AT CLINICAL HIGH-RISK FOR PSYCHOSIS.

Lisa A Bartolomeo1, Molly A Erickson2, Lauren E Arnold1, Gregory P Strauss1.   

Abstract

PURPOSE OF THE REVIEW: Negative symptoms are highly predictive of whether individuals at clinical high-risk (CHR) develop a psychotic disorder. However, little is known about pathophysiological mechanisms underlying negative symptoms during this period. The current study examined neurophysiological mechanisms underlying negative symptoms in CHR individuals using electroencephalography frontal alpha asymmetry power, a biomarker of approach and avoidance motivation. RECENT
FINDINGS: People with schizophrenia display abnormal patterns of frontal alpha asymmetry indicative of reduced approach motivation. However, It is unknown whether similar abnormalities occur in CHR youth that predict negative symptoms.
SUMMARY: Results indicated that CHR and healthy controls did not differ in frontal alpha asymmetry scores. However, in CHR youth, frontal alpha asymmetry was inversely correlated with the motivation and pleasure dimension of negative symptoms, which was accounted for by mood symptoms. Findings suggest that depression contributes to reduced approach motivation in CHR youth that manifests clinically as negative symptoms.

Entities:  

Keywords:  Frontal alpha asymmetry; anhedonia; avolition; negative symptoms; prodrome; psychosis

Year:  2019        PMID: 31857941      PMCID: PMC6922025     

Source DB:  PubMed          Journal:  Curr Behav Neurosci Rep


  28 in total

Review 1.  Anterior cerebral asymmetry and the nature of emotion.

Authors:  R J Davidson
Journal:  Brain Cogn       Date:  1992-09       Impact factor: 2.310

Review 2.  Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions.

Authors:  Deanna M Barch; Erin C Dowd
Journal:  Schizophr Bull       Date:  2010-06-21       Impact factor: 9.306

3.  EEG alpha asymmetry in schizophrenia, depression, PTSD, panic disorder, ADHD and conduct disorder.

Authors:  Evian Gordon; Donna M Palmer; Nicholas Cooper
Journal:  Clin EEG Neurosci       Date:  2010-10       Impact factor: 1.843

4.  A capability model of individual differences in frontal EEG asymmetry.

Authors:  James A Coan; John J B Allen; Patrick E McKnight
Journal:  Biol Psychol       Date:  2005-11-28       Impact factor: 3.251

5.  Resting frontal EEG asymmetry and shyness and sociability in schizophrenia: a pilot study of community-based outpatients.

Authors:  Michelle K Jetha; Louis A Schmidt; Joel O Goldberg
Journal:  Int J Neurosci       Date:  2009       Impact factor: 2.292

6.  Preliminary psychometric properties of the brief Negative Symptom Scale in youth at Clinical High-Risk for psychosis.

Authors:  Gregory P Strauss; Hannah C Chapman
Journal:  Schizophr Res       Date:  2017-08-03       Impact factor: 4.939

Review 7.  Symptom assessment in schizophrenic prodromal states.

Authors:  T J Miller; T H McGlashan; S W Woods; K Stein; N Driesen; C M Corcoran; R Hoffman; L Davidson
Journal:  Psychiatr Q       Date:  1999

8.  Neuroleptic-free youth at ultrahigh risk for psychosis evidence diminished emotion reactivity that is predicted by depression and anxiety.

Authors:  June Gruber; Gregory P Strauss; Laure Dombrecht; Vijay A Mittal
Journal:  Schizophr Res       Date:  2017-08-12       Impact factor: 4.939

9.  A review of reward processing and motivational impairment in schizophrenia.

Authors:  Gregory P Strauss; James A Waltz; James M Gold
Journal:  Schizophr Bull       Date:  2013-12-27       Impact factor: 9.306

10.  Approach and withdrawal motivation in schizophrenia: an examination of frontal brain asymmetric activity.

Authors:  William P Horan; Jonathan K Wynn; Ian Mathis; Gregory A Miller; Michael F Green
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

View more
  1 in total

1.  The impact of the COVID-19 pandemic on negative symptoms in individuals at clinical high-risk for psychosis and outpatients with chronic schizophrenia.

Authors:  Gregory P Strauss; Kelsey I Macdonald; Ivan Ruiz; Ian M Raugh; Lisa A Bartolomeo; Sydney H James
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-04-21       Impact factor: 5.270

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.